• Biobide publishes the results of its zebrafish research in the journal Oncogene

• Biobide is a biotechnology company that specialises in zebrafish, which share 85% of their DNA with humans and whose transparent embryos develop in 24-48 hours. These properties allow the effects produced upon administration of new compounds to be studied more cheaply and in a shorter time period than with other animal models.

• Read more >>

• January 27, 2012

• Biolan Biosensors will monitor the health of Chilean table grapes

• Biolan Microbiosensores has signed an agreement with the Chilean Agricultural Research Institute (INIA) to monitor the health of table grapes in that country during the campaign that starts in the next few weeks.

• Read more >>

• January 23, 2012

• CIC bioGUNE celebrates its seventh anniversary

• The Center for Cooperative Research in Biosciences CIC bioGUNE is to celebrate its seventh anniversary with a plenary lecture from Dr. Luis Serrano, Head of the Center for Genomic Regulation (CRG) in Barcelona, entitled “Systems biology analysis of a small bacterium: lessons in humility”.

• Read more >>

• January 20, 2012

• Histocell develops a cell therapy-based lung treatment together with CSIC and the Hospital Clinic

• Histocell, which specialises in regenerative medicine, has invested 3 million euros to develop a cell-based drug for pulmonary fibrosis based on research begun by Dr. Anna Serrano, from the Spanish National Research Council (CSIC), and Dr. Antoni Xaubet, from the Clinic Hospital in 2004. The results of this study showed that certain lung cells could be used to recover lost lung function in patients suffering from pulmonary fibrosis.

• Read more >>

• January 19, 2012

• Abbott and CIC biomaGUNE sign an agreement to study the effect of diet on memory and the ageing process

• The Center for Cooperative Research in Biomaterials, CIC biomaGUNE, has signed a research contract worth 225,000 euros with Abbott, an international biomedical company that specialises in pharmaceutical, nutritional, health-care and diagnostic products, to study the effect of diet on memory and the ageing process using magnetic resonance imaging (MRI) and positron emission tomography (PET) techniques in animal models (rats and mice).

• Read more >>

• January 16, 2012

• Tecnalia develops new products from unused fruit and vegetable waste

• The technology corporation Tecnalia is leading the international Transbio project, which will use biotechnology solutions - such as fermentation and enzymatic processes - to obtain new high-value products - like new materials to replace current plastics, food ingredients and enzymes for use in detergents - from raw materials and unused products from the fruit- and vegetable-processing industry.

• Read more >>

• January 15, 2012

• CIC bioGUNE researchers discover a new therapeutic target to fight liver cancer

• A group of researchers of the Metabolomics Unit of CIC bioGUNE, led by Dr. Martinez Chantar, has taken a new step in the study of liver cancer, revealing the molecular mechanism, which was unknown until now, involved in the development of hepatocellular carcinoma. They observed how the malignancy of this disease may be related with overexpression of a protein, HuR.

• Read more >>

• January 13, 2012

• Creation of the Bioelectronics Aula

• The Bioelectronics Workshop is the result of a framework collaboration agreement, known as Engineering and Science, between the University School of Industrial Engineering, Bilbao, the University of the Basque Country and the Academy of Medical Sciences.

• Read more >>

• January 12, 2012

• Tecnalia and Donostia Hospital develop a breath-based sensor for detecting lung cancer

• Tecnalia and the Donostia Hospital are participating in the Interreg Medisen project, which aims to develop biosensors that are able to detect early-stage lung cancer via the breath. The breath of both healthy and sick humans contains numerous organic compounds, such as acetone, methanol, butanol and hydrocarbons. When a person falls sick, the changes occurring inside their body are reflected in their breath, which could therefore allow the presence of certain biomarkers to be detected.

• Read more >>

• January 9, 2012

• A&B Laboratories launches a range of chemical and environmental risk-free biological cleaning products

• A&B Laboratories, a company concerned with the design, manufacture and marketing of chemical and biological products, has recently launched a range of new domestic cleaning and disinfection products, namely Befreehome, with no chemical or environmental risk. These products will be sold via a web page created for this purpose (ab-befreehome.com).

• Read more >>

• January 3, 2012

More news of 2011

• December 23, 2011 > IkerChem increases its capital with investments from venture capital firms

• December 20, 2011 > The Santiago Apóstol Hospital takes part of a pioneer European clinical trial to treat acute mania in bipolar disorder

• December 15, 2011 > Genetadi Biotech develops genetic test to diagnose idiopathic mental retardation

• December 14, 2011 > Neiker-Tecnalia cultivates in vitro microalgae to obtain nutritional molecules for the food industry

• December 10, 2011 > High Identity Buildings plans innovative and sustainable labs for biosciences

• December 9, 2011 > The Biodonostia Institute studies the genetic mutations responsible for retinitis

• December 7, 2011 > Basque Biobank launches brain donation programme

• December 5, 2011 > The University of the Basque Country discovers new pathways towards anti-stress medications

• December 2, 2011 > Biolan analyses grape quality in the Rioja Alavesa using remote measuring systems

• December 1, 2011 > FAES signs an agreement with Kalbe Pharma to market Bilastine in Indonesia